6 60 DEGREES PHARMACEUTICALS, INC.: management transactions · United States · SEC (Form 4) Browse the full management transaction log of 60 DEGREES PHARMACEUTICALS, INC., a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €3.9m. The latest transaction was filed on 16 December 2025 (Acquisition). Among the most active insiders: DOW GEOFFREY S. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 16 December 2025
All Executives18 Thresholds0 Prospectus0 Other0
Declarations 18 total
▲ President and CEO · Executives · 15 Dec 2025
9,670 shares @ US$0.8024 11.7% of flow Common Stock SEC:0001213900-25-122379:0
Ideal exit: 11 Sept 2026 (T+270) ◆ CFO · Executives · 17 Jan 2025
11,626 shares 0Common Stock SEC:0001213900-25-005051:0
◆ President and CEO · Executives · 17 Jan 2025
14,394 shares 0Common Stock SEC:0001213900-25-005055:0
▲ Director · Executives · 12 Dec 2024
2,500 shares @ US$1.85 5.4% of flow Common Stock SEC:0001213900-24-110269:0
Ideal exit: 8 Sept 2025 (T+270) ▲ President and CEO · Executives · 5 Dec 2024
17,549 shares @ US$1.1123 32.8% of flow Common Stock SEC:0001213900-24-107011:0
Ideal exit: 1 Sept 2025 (T+270) ▲ President and CEO · Executives · 19 Nov 2024
2,500 shares @ US$0.8992 3.7% of flow Common Stock SEC:0001213900-24-101110:0
Ideal exit: 16 Aug 2025 (T+270) ▲ Director · Executives · 27 Aug 2024
5,000 shares @ US$1.70 9.3% of flow Common Stock SEC:0001213900-24-077746:0
Ideal exit: 24 May 2025 (T+270) ◆ Director · Executives · 16 May 2024
4,000 shares @ US$0.223 100.0% of flow Common Stock SEC:0001213900-24-045708:0
◆ CFO · Executives · 16 May 2024
15,000 shares @ US$0.223 17.1% of flow Common Stock SEC:0001213900-24-045707:1
◇ Director · Executives · 16 May 2024
4,000 shares @ US$0.223 100.0% of flow Common Stock SEC:0001213900-24-045706:0
◇ Director · Executives · 16 May 2024
2,000 shares @ US$0.223 0.5% of flow Common Stock SEC:0001213900-24-045709:0
◇ Director · Executives · 16 May 2024
4,000 shares @ US$0.223 100.0% of flow Common Stock SEC:0001213900-24-045704:0
◇ President and CEO · Executives · 12 Apr 2024
68,000 shares @ US$0.2668 29.8% of flow Common Stock SEC:0001213900-24-045705:0
◆ CFO · Executives · 12 Apr 2024
60,000 shares @ US$0.2668 82.9% of flow Common Stock SEC:0001213900-24-045707:0
◇ President and CEO · Executives · 16 May 2024
17,000 shares @ US$0.223 6.2% of flow Common Stock SEC:0001213900-24-045705:1
45,560 shares @ US$4.745 100.0% of flow Common Stock, $0.0001 par value per share ("Common Shares") SEC:0001140361-24-017682:0
▲ President and CEO · Executives · 31 Jan 2024
25,974 shares @ US$0.375 15.8% of flow Common Stock SEC:0001213900-24-009603:0
Ideal exit: 27 Oct 2024 (T+270) ▲ Director · Executives · 31 Jan 2024
200,000 shares @ US$0.375 84.8% of flow Common Stock SEC:0001213900-24-009599:0
Ideal exit: 27 Oct 2024 (T+270)